Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 11,019 | 8,268 | 6,200 | 5,774 | 2,780 |
| Operating Income | -11,019 | -8,268 | -6,200 | -5,774 | -2,780 |
| Other Income | 109 | 48 | 16 | -1 | -1 |
| Pre-tax Income | -10,910 | -8,220 | -6,184 | -5,775 | -2,781 |
| Net Income Continuous | -10,910 | -8,223 | -6,184 | -5,775 | -2,781 |
| Net Income | $-10,910 | $-8,223 | $-6,184 | $-5,775 | $-2,781 |
| EPS Basic Total Ops | -15.79 | 1,181.75 | -9.12 | -835.09 | -403.16 |
| EPS Basic Continuous Ops | -15.68 | 1,178.98 | -9.08 | -833.87 | -401.56 |
| EPS Diluted Total Ops | -15.79 | 1,181.75 | -9.12 | -835.09 | -403.16 |
| EPS Diluted Continuous Ops | -15.68 | 1,178.98 | -9.08 | -833.87 | -401.56 |
| EBITDA(a) | $-10,979 | $-8,244 | $-6,197 | $-5,772 | $-2,778 |